Looking for representation in the Xarelto lawsuit? Our experience, expertise, and resources make Hollis Law the ideal partner.
The Hollis Law Firm represents several clients all over the United States who have claims against the manufacturers of defective drugs and medical devices, focusing exclusively on these types of cases. The Hollis Law Firm has recovered over 93 million dollars in settlement payments for the hundreds of clients who have been injured by dangerous drugs and medical devices.
f you’ve been affected by this drug, contact us to learn how we can represent you in the Xarelto lawsuit.
Call the Hollis Law Firm at 1-800-701-3672 if you or a loved one has suffered from damages related to the use of this product. All calls and case evaluations are free and carry no obligation. The Hollis Law Firm works on cases on a contingent fee basis, which means we don’t get paid if you don’t get paid. Call 1-800-701-3672 to speak to one of our trained intake specialist so that your potential claim can be reviewed by an attorney at the Hollis Law Firm. The injuries and damages caused by contaminated products will not be uniform; therefore, claims will need to proceed on an individual basis and not as part of a class action.
Xarelto (Rivaroxaban) is a relatively new anti-coagulant (blood thinner). The Food & Drug Administration (FDA) initially approved Xarelto in July 2011 for use following knee and hip surgery to reduce the risks of deep vein thrombosis (DVT). In November 2011, the FDA approved the drug for additional use as an anti-coagulant in individuals with non-valvular atrial fibrillation.\
History of the Case
In November 2012, the FDA extended approval to patients with DVT and pulmonary embolism as well as for long-term treatment to prevent recurrence. Xarelto users sued Johnson & Johnson, Janssen Pharmaceuticals and Bayer Corporation, claiming they suffered from internal bleeding, wound leakage and infections after taking the popular anti-clotting drug. The drug’s makers won six trials but agreed to settle thousands of lawsuits for $775 million in March 2019.
Injuries Related to Product
– Uncontrollable Bleeding
– Wound Infections
– Stevens-Johns Syndrome (SJS)